First Procedure In U.S. Trial For SprayGelTM Adhesion Barrier

From: Helen Dynda (
Wed Jul 17 16:05:16 2002

Confluent Surgical Announces First Procedure In U.S. Trial for SprayGel Adhesion Barrier

Waltham, MA – June 17, 2002 – Confluent Surgical, Inc., today announced the commencement of its pivotal U.S. trial for the SprayGel Adhesion Barrier in Prevention of Pelvic Adhesions In Laparoscopic Surgery, the PREVAIL Study. Confluent Surgical believes that the SprayGel Adhesion Barrier will prevent and reduce adhesions that are associated with severe postoperative pain and other side effects, which affect millions of women annually.

Enter keywords:
Returns per screen: Require all keywords: